GERON

Serial Number 97110430
Registration 7081994
700

Registration Progress

Application Filed
Nov 5, 2021
Under Examination
Mar 22, 2022
Approved for Publication
Jan 25, 2022
Published for Opposition
Jan 25, 2022
Registered
Jun 13, 2023

Trademark Image

GERON

Basic Information

Serial Number
97110430
Registration Number
7081994
Filing Date
November 5, 2021
Registration Date
June 13, 2023
Published for Opposition
January 25, 2022
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 13, 2023
Registration
Registered
Classes
005 035 044

Rights Holder

Geron Corporation

03
Address
919 E. Hillsdale Blvd., Suite 250
Foster City, CA 94404

Ownership History

Geron Corporation

Original Applicant
03
Foster City, CA

Geron Corporation

Owner at Publication
03
Foster City, CA

Geron Corporation

Original Registrant
03
Foster City, CA

Legal Representation

Attorney
Sharon R. Smith

USPTO Deadlines

Next Deadline
1429 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-06-13)
Due Date
June 13, 2029
Grace Period Ends
December 13, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

31 events
Date Code Type Description Documents
Nov 20, 2024 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Jun 13, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jun 13, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
May 9, 2023 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
May 8, 2023 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Apr 7, 2023 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Apr 7, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Mar 21, 2023 IUAF S USE AMENDMENT FILED Loading...
Mar 21, 2023 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Feb 15, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 15, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Feb 15, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Sep 15, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 13, 2022 EX1G S SOU EXTENSION 1 GRANTED Loading...
Sep 13, 2022 EXT1 S SOU EXTENSION 1 FILED Loading...
Sep 13, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 22, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 25, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 25, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 5, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 22, 2021 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Dec 22, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 14, 2021 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Dec 14, 2021 ALIE A ASSIGNED TO LIE Loading...
Dec 13, 2021 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Dec 13, 2021 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Dec 13, 2021 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Dec 13, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 16, 2021 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Nov 15, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 9, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Therapeutic, diagnostic, and prophylactic preparations, pharmaceutical products and agents for the treatment, diagnosis or prophylaxis of human diseases, disorders and conditions, namely, cancers and hematologic diseases, syndromes and disorders
First Use Anywhere: Jan 25, 2023
First Use in Commerce: Jan 25, 2023
Class 035
Promoting collaboration within the scientific, research and provider communities to achieve advances in the fields of treatment, diagnosis and prophylaxis of cancers and hematologic diseases, syndromes and disorders
First Use Anywhere: Nov 18, 2021
First Use in Commerce: Nov 18, 2021
Class 044
Providing medical information in the field of the diagnosis and treatment of cancers and hematologic malignancies to consumers, and providing medical information in the field of prevention, screening, diagnosis and treatment to scientists, researchers and medical providers on cancers and hematologic diseases, syndromes and disorders
First Use Anywhere: Nov 18, 2021
First Use in Commerce: Nov 18, 2021

Additional Information

Design Mark
The mark consists of four vertical lines that curve on both ends and curve inwards towards the other lines with the word "GERON" to the right of the design.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005 035 044